This is a list of all Hepatology related medical scores and algorithms with their corresponding calculator/app.
Helps you convert cholesterol (TC, HDL, LDL) and triglyceride measurements from mmol/L to mg/dL and the other way around.
Determines insulin resistance and can also identify individuals at risk for NAFLD.
Compares the amount of albumin proteins found in blood with that of other proteins, the globulins.
Predicts FL in general population based on BMI, waist circumference, triglycerides & GGT.
Distinguishes between alcoholic liver disease and non-alcoholic fatty liver disease to help with ALD diagnosis.
Determines the likelihood of NAFLD diagnosis based on patient gender, AST, ALT and BMI.
Predicts short term prognosis in patients with alcoholic hepatitis (AH) and helps prioritize steroid therapy.
Evaluates liver fibrosis based on age, platelet count, AST and ALT to help with cirrhosis diagnosis.
Determines very low-density lipoprotein cholesterol based on triglycerides value from lipid profile.
Evaluates hepatic function via parameters and computes a series of liver scores from MELD to Fatty Liver Index based on laboratory and patient data.
Assesses chronic liver disease severity based on the new MELD calculation that includes serum sodium.
Determines the degree of hepatic fibrosis in patients with non-alcoholic fatty liver disease.
Evaluates severity of chronic liver cirrhosis based on five patient parameters.
Predicts mortality risk in patients diagnosed with alcoholic hepatitis that is not responding to steroid therapy.
Estimates liver failure risk in patients treated of primary biliary cholangitis with Ursodeoxycholic acid (UDCA).
Helps with cirrhosis diagnosis based on the platelet count and AST level.
Determines the MELD from INR, creatinine and bilirubin and stratifies survival in patients with end of stage liver disease.
Assesses if referral for liver transplantation is possible for both acetaminophen and non-acetaminophen induced toxicity.
Evaluates the severity of liver disease in pediatric patients for transplant waiting list, based on albumin, bilirubin and INR.
Assigns an AAST grade of liver trauma severity based on hepatic hematoma and degree of laceration.
Determines the survival rate of patients with portal hypertension after TIPS.
Determines whether the cause of ascites is portal hypertension or rules it out.
Evaluates whether cirrhosis and hepatocellular carcinoma patients are viable liver transplantation (OLT) candidates.
Predicts survival of patients with hepatocellular carcinoma (HCC) based on two markers of liver function, albumin and bilirubin.
